Mitochondrial Electron Transport Is the Cellular Target of the Oncology Drug Elesclomol

Elesclomol is a first-in-class investigational drug currently undergoing clinical evaluation as a novel cancer therapeutic. The potent antitumor activity of the compound results from the elevation of reactive oxygen species (ROS) and oxidative stress to levels incompatible with cellular survival. Ho...

全面介绍

Saved in:
书目详细资料
Main Authors: Ronald K. Blackman, Kahlin Cheung-Ong, Marinella Gebbia, David A. Proia, Suqin He, Jane Kepros, Aurélie Jonneaux, Philippe Marchetti, Jérôme Kluza, Patricia E. Rao, Yumiko Wada, Guri Giaever, Corey Nislow
格式: Artigo
语言:英语
出版: 2012
在线阅读:https://doi.org/10.1371/journal.pone.0029798
https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0029798&type=printable
标签: 添加标签
没有标签, 成为第一个标记此记录!